Alexandrov Andrei, Shu Mei-Di, Steitz Joan A
Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT 06536, USA.
Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT 06536, USA.
Mol Cell. 2017 Jan 5;65(1):191-201. doi: 10.1016/j.molcel.2016.11.032. Epub 2016 Dec 22.
Nonsense-mediated decay (NMD) degrades mRNAs containing a premature termination codon (PTC). PTCs are a frequent cause of human genetic diseases, and the NMD pathway is known to modulate disease severity. Since partial NMD attenuation can potentially enhance nonsense suppression therapies, better definition of human-specific NMD is required. However, the majority of NMD factors were first discovered in model organisms and then subsequently identified by homology in human. Sensitivity and throughput limitations of existing approaches have hindered systematic forward genetic screening for NMD factors in human cells. We developed a method of in vivo amplification of NMD reporter fluorescence (Fireworks) that enables CRISPR-based forward genetic screening for NMD pathway defects in human cells. The Fireworks genetic screen identifies multiple known NMD factors and numerous human candidate genes, providing a platform for discovery of additional key factors in human mRNA degradation.
无义介导的mRNA降解(NMD)可降解含有提前终止密码子(PTC)的mRNA。PTC是人类遗传疾病的常见病因,已知NMD途径可调节疾病严重程度。由于部分NMD减弱可能会增强无义抑制疗法,因此需要更好地定义人类特异性NMD。然而,大多数NMD因子最初是在模式生物中发现的,随后通过在人类中的同源性鉴定出来。现有方法的灵敏度和通量限制阻碍了对人类细胞中NMD因子进行系统性正向遗传筛选。我们开发了一种体内NMD报告荧光扩增方法(Fireworks),该方法能够对人类细胞中NMD途径缺陷进行基于CRISPR的正向遗传筛选。Fireworks遗传筛选鉴定出多个已知的NMD因子和众多人类候选基因,为发现人类mRNA降解中的其他关键因子提供了一个平台。